A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study ; volume:20 ; number:1 ; day:2 ; month:2 ; year:2021 ; pages:1-13 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (2.2.2021), 1-13, 12.2021
- Urheber
-
Hiruma, Shigenori
Shigiyama, Fumika
Hisatake, Shinji
Mizumura, Sunao
Shiraga, Nobuyuki
Hori, Masaaki
Ikeda, Takanori
Hirose, Takahisa
Kumashiro, Naoki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01228-3
- URN
-
urn:nbn:de:101:1-2021032620080051477194
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hiruma, Shigenori
- Shigiyama, Fumika
- Hisatake, Shinji
- Mizumura, Sunao
- Shiraga, Nobuyuki
- Hori, Masaaki
- Ikeda, Takanori
- Hirose, Takahisa
- Kumashiro, Naoki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study
Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR
Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
Predicting cardiac arrest after neonatal cardiac surgery
Traumatic cardiac arrest – a nationwide Danish study
Cardiac CT
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study
Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR
Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
Predicting cardiac arrest after neonatal cardiac surgery
Traumatic cardiac arrest – a nationwide Danish study
Cardiac CT
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
Incidence of cardiac sarcoidosis in those with extra-cardiac disease without known cardiac involvement - a CMR study
Examining the relationship between cardiac troponin T and cardiac morphology, function, and fibrosis - a cardiac magnetic resonance study
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR
Adverse cardiac events of hypercholesterolemia are enhanced by sitagliptin in sprague dawley rats
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
Predicting cardiac arrest after neonatal cardiac surgery
Traumatic cardiac arrest – a nationwide Danish study